BioHarvest Sciences Inc.

As of December 31, 2024, BioHarvest Sciences Inc. has 17.33M shares outstanding.

These figures are as of December 31, 2024. The price-to-sales ratio is 3.84, and the price-to-book ratio stands at 72.70.

These figures are as of December 31, 2024. The EV/Sales ratio of 4.29 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. BioHarvest Sciences Inc. trades at an EV/FCF ratio of 45.89, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.

As of December 31, 2024, BioHarvest Sciences Inc. maintains a current ratio of 0.55, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1,038.95, indicating moderate leverage, while an interest coverage ratio of -0.92 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended December 31, 2024. Return on assets (ROA) is negative at -64.56, reflecting losses generated across the asset base. Inventory turnover of 3.67 indicates how many times BioHarvest Sciences Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on February 14, 2025, BioHarvest Sciences Inc.'s stock has gained approximately 5.58% over the past 52 weeks. The 50-day moving average sits at 8.36, while the 200-day moving average is 8.08.

Over the twelve months ended December 31, 2024, BioHarvest Sciences Inc. posted a gross margin of 55.35, reflecting its pricing power and cost economics. The operating margin of -27.75 and net profit margin of -51.27 provide insight into operational efficiency.

These figures cover the twelve months ended December 31, 2024. Free cash flow yield is negative at -3.98: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -7.01, meaning BioHarvest Sciences Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

BioHarvest Sciences Inc.'s most recent stock split took place on June 3, 2024 with a 35:1 split ratio.

As of December 31, 2024, BioHarvest Sciences Inc. has an Altman Z-Score of -3.17, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.